DGAP-News: Celesio AG / Key word(s): Final Results
Celesio AG: Celesio announces results for fiscal 2014
17.03.2015 / 10:00
---------------------------------------------------------------------
Celesio announces results for fiscal 2014
- Guaranteed dividend amounting to 0.83 euro
Stuttgart, 17 March 2015. Celesio generated group revenue of 22,325.9
million euro in fiscal 2014, which is up 4.3 per cent year-on-year. When
adjusted for currency effects, revenue actually increased by 4.2 per cent.
Market growth in Germany as well as in Brazil and the good revenue
performance in the United Kingdom, in Austria and in Norway more than
compensated the loss in revenue of the Irish wholesale business, which was
consolidated until May 2013. Adjusted earnings before interest and taxes
(EBIT) fell by 3.0 per cent from 423.6 million euro to 410.9 million euro.
On an operational basis, in particular the very good performance in the
United Kingdom and Norway as well as supportive developments in other
countries could compensate for the unfavourable trends in Brazil and
France. EBIT was impacted by one-off effects in Brazil and Portugal.
Performance in the divisions
Revenue in the Consumer Solutions division - the pharmacy business -
increased by 7.8 per cent from 3,411.9 million euro to 3,677.8 million
euro. After adjustments for currency effects, revenue rose by 5.5 per cent.
After adjustments for non-recurring effects, EBIT increased significantly
by 26.7 per cent from the previous year's figure of 206.9 million euro to
262.0 million euro in 2014. This development is mainly driven by the
substantial positive contribution from the reduction in pension costs in
Norway and purchasing activities which improved earnings in all countries.
Revenue in the Pharmacy Solutions division - the wholesale business -
increased by 3.6 per cent from 17,996.0 million euro to 18,648.6 million
euro. After adjustments for currency effects, revenue increased by 4.0 per
cent.
After adjustments for non-recurring effects, EBIT decreased by 23.3 per
cent from 307.3 million euro to 235.8 million euro. On the one hand there
was a favourable development in the United Kingdom, in Norway and in
Austria; on the other hand challenging conditions prevailed in Germany, in
Brazil, in Portugal, in France and in Belgium.
Dividend for 2014
As the domination and profit and loss transfer agreement between Celesio AG
and McKesson Deutschland GmbH & Co. KGaA became effective on 2 December
2014, the guaranteed dividend amounting to 0.83 euro is granted for fiscal
2014 by McKesson Deutschland.
Earnings forecast
In addition to cost structures, we will also continue optimizing the
efficiency of our companies. However, the development of the upcoming short
fiscal 2015 will be burdened by government intervention in several markets
accompanied by special effects from the integration process and the ongoing
challenging environment in Germany, in Brazil, in France and in Belgium.
Therefore the Management Board expects revenue to increase moderately, and
adjusted EBIT to be slightly below the unaudited figures for the first
quarter 2014. Overall, Celesio assumes that both revenue and adjusted EBIT
for fiscal 2016 will return to the level of fiscal 2014.
<pre>
Key figures of the 2013 2014 Change on EUR
Celesio Group basis in %
Continuing operations
Revenue EUR m 21,407.7 22,325.9 4.3
EBITDA EUR m 532.8 487.4 -8.5
adjusted1) EUR m 548.6 532.2 -3.0
EBIT EUR m 406.6 237.0 -41.7
adjusted1) EUR m 423.6 410.9 -3.0
Net profit/loss EUR m 171.2 52.9 -69.1
adjusted1) EUR m 186.4 216.6 16.2
Free cash flow EUR m 242.8 -14.6 /
Retail pharmacies3) 2,175 2,184 /
Wholesale branches3) 133 133 /
Discontinued operations
Net profit/loss EUR m -4.8 -0.5 89.6
Continuing and
discontinued operations
Net Financial Debt EUR m 1,363.42) 867.03) -36.4
Net Financial Debt/ 2.492) 1.633) /
EBITDA adj. 1) 4)
Employees3) 38,871 38,788 /
Net profit/loss EUR m 166.4 52.4 /
Earnings per share (basic) EUR 0.94 0.25 /
</pre>
1) Adjusted for special effects from defined non-recurring expenses and
income (including tax effect).
2) Closing figures as at 31 December 2013.
3) Closing figures at the end of the reporting period.
4) Based on EBITDA of the last twelve months.
Press Contact
Marc Binder, Celesio AG, +49 (0) 711.5001-380
media@celesio.com
Rainer Berghausen, Celesio AG, +49 (0) 711.5001-549
media@celesio.com
Investor Relations
Michael Otto, Celesio AG, +49 (0) 711.5001-635
investor@celesio.com
Creditor Relations
Marcus Hilger, Celesio AG, +49 (0) 711.5001-532
finance@celesio.com
Tobias Mommertz, Celesio AG, +49 (0) 711.5001-395
finance@celesio.com
About the Celesio Group
Celesio is a leading international wholesale and retail company and
provider of logistics and services to the pharmaceutical and healthcare
sectors. The proactive and preventive approach ensures that patients
receive the products and support that they require for optimum care. With
some 39,000 employees, Celesio operates in 14 countries around the world.
Every day, the group serves over 2 million customers - at about 2,200
pharmacies of its own and over 4,300 participants in brand partnership
schemes. With 133 wholesale branches, Celesio supplies 65,000 pharmacies
and hospitals every day with up to 130,000 pharmaceutical products. The
services benefit a patient pool of about 15 million per day.
McKesson Corporation, San Francisco, USA, is the majority shareholder in
Celesio AG. The company acquired more than 75 percent of Celesio AG shares
in February 2014. McKesson provides solutions that include pharmaceutical
and medical-surgical supply management, healthcare information technology,
and business and clinical services.
---------------------------------------------------------------------
17.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: investor@celesio.com
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime
Standard), Munich, Stuttgart; Regulated Unofficial Market
in Hamburg, Hanover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
333849 17.03.2015
DGAP-News: Celesio AG: Celesio announces results for fiscal 2014
| Source: EQS Group AG